What novel dosing schedules and combination regimens are being investigated for oral agents commonly deployed and guideline-endorsed to treat MAC lung disease?

What novel dosing schedules and combination regimens are being investigated for oral agents commonly deployed and guideline-endorsed to treat MAC lung disease?

What novel dosing schedules and combination regimens are being investigated for oral agents commonly deployed and guideline-endorsed to treat MAC lung disease? 


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Julie Philley, MD

Julie Philley, MD

Chair of the Department of Medicine
Chief of Pulmonary and Critical Care
UT Health North Campus Tyler
The University of Texas Health Sciences Center
Houston, Texas